A Secret Weapon For M3541
The key end issue was the protection and tolerability of sifalimumab. Remedy-emergent adverse occasions (AEs) and significant AEs (SAEs) as well as their severity, final result, and any connection on the research medication were recorded with the investigator throughout the examine. AEs were thought of prone to be linked to analyze medication whene